secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2024-11-01T23:59:59+00:00
Accession:  0001193125-24-249270
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics receives Nasdaq extension until March 4, 2025 to regain minimum equity compliance
--------------------------------------------------------------------------------

- Nasdaq Hearings Panel granted extension to March 4, 2025 for Plus Therapeutics to meet $2.5M stockholders' equity minimum.
- Company has been non-compliant since March 8, 2024; hearing was held on October 22, 2024.
- No assurance of regaining compliance; delisting risk remains if equity condition not met by deadline.
- Stock continues trading on Nasdaq Capital Market under ticker PSTV during extension period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312524249270/0001193125-24-249270-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312524249270/d860547d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-249270

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer